| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.045 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.041 | 0.8 |